OLD Mission Capital LLC increased its stake in shares of Sanofi SA (NYSE:SNY) by 250.4% in the fourth quarter, HoldingsChannel reports. The firm owned 280,376 shares of the company’s stock after buying an additional 200,355 shares during the quarter. Sanofi comprises approximately 0.6% of OLD Mission Capital LLC’s investment portfolio, making the stock its 25th biggest position. OLD Mission Capital LLC’s holdings in Sanofi were worth $12,056,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in the stock. Deutsche Bank AG increased its position in Sanofi by 369.7% in the 4th quarter. Deutsche Bank AG now owns 1,462,947 shares of the company’s stock valued at $62,903,000 after acquiring an additional 1,151,455 shares during the period. Fisher Asset Management LLC increased its position in Sanofi by 3.0% in the 4th quarter. Fisher Asset Management LLC now owns 14,500,758 shares of the company’s stock valued at $623,533,000 after acquiring an additional 418,501 shares during the period. Renaissance Group LLC acquired a new position in Sanofi in the 3rd quarter valued at approximately $16,239,000. Senzar Asset Management LLC increased its position in Sanofi by 25.4% in the 4th quarter. Senzar Asset Management LLC now owns 999,786 shares of the company’s stock valued at $42,990,000 after acquiring an additional 202,300 shares during the period. Finally, Southpoint Capital Advisors LP increased its position in Sanofi by 10.0% in the 4th quarter. Southpoint Capital Advisors LP now owns 2,200,000 shares of the company’s stock valued at $94,600,000 after acquiring an additional 200,000 shares during the period. Institutional investors and hedge funds own 8.94% of the company’s stock.
Shares of Sanofi SA (NYSE:SNY) opened at $40.70 on Tuesday. Sanofi SA has a 12-month low of $38.14 and a 12-month high of $50.65. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.26 and a current ratio of 1.70. The firm has a market cap of $101,843.71, a price-to-earnings ratio of 11.14, a PEG ratio of 2.15 and a beta of 0.92.
The company also recently disclosed an annual dividend, which will be paid on Monday, June 4th. Stockholders of record on Thursday, May 10th will be given a dividend of $1.8609 per share. The ex-dividend date of this dividend is Wednesday, May 9th. This is a boost from Sanofi’s previous annual dividend of $1.58. This represents a dividend yield of 4.72%. Sanofi’s dividend payout ratio is 30.14%.
Several equities analysts have issued reports on the stock. Deutsche Bank restated a “buy” rating on shares of Sanofi in a research report on Monday. Sanford C. Bernstein restated a “market perform” rating and issued a $45.00 price target (down from $50.00) on shares of Sanofi in a research report on Thursday, February 8th. ValuEngine cut shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Zacks Investment Research cut shares of Sanofi from a “hold” rating to a “sell” rating in a research report on Wednesday, February 14th. Finally, Bank of America cut shares of Sanofi from a “buy” rating to a “neutral” rating in a research report on Wednesday, December 6th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average target price of $49.33.
Sanofi is a healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. Its segments are Pharmaceuticals, Human Vaccines (Vaccines), and Other. The Pharmaceuticals segment comprises the commercial operations of various franchises, including Speciality Care (Rare Diseases, Multiple Sclerosis, and Oncology), Diabetes and Cardiovascular, Established Prescription Products, Consumer Healthcare and Generics, and research and development, production and marketing activities for all of the Company’s pharmaceuticals operations.
Want to see what other hedge funds are holding SNY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sanofi SA (NYSE:SNY).
Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.